M-A: Fracture risk is lower in patients anticoagulated with NOACs compared to patients treated with warfarin
26 Mar, 2021 | 08:26h | UTCCommentary: NOACs associated with a 16% lower risk of bone fractures than warfarin – Cardiovascular Business
Commentary: NOACs associated with a 16% lower risk of bone fractures than warfarin – Cardiovascular Business